大多数腹部白性胆固醇神经元正在爆发的基础前脑胆固醇神经元与 mesocorticolimbic 连接性
Dániel Schlingloff1,2, Írisz Szabó1, Éva Gulyás1,2
1MTA-HUN-REN KOKI Lendület "Momentum" Laboratory of Systems Neuroscience, HUN-REN Institute of Experimental Medicine, H-1083, Budapest, Hungary.
概括
腹皮胆固醇神经元 (VPCNs) 类似于基底前脑神经元,而不是条状神经元. 这些VPCN传递厌恶和食欲刺激信息以奖励电路,可能影响情绪障碍和成.
科学领域:
- 神经科学是一个神经科学.
- 神经解剖学是一个神经解剖学.
- 神经生理学 神经生理学
背景情况:
- 腹 (VP) 整合了基底和基底前脑电路.
- 基底前脑和条纹体中的胆神经元具有不同的特征.
- 腹神经元 (VPCNs) 中胆性神经元的性质仍然不太清楚.
研究的目的:
- 描述VPCN的解剖学和功能性质.
- 为了确定VPCN是否类似于基底前脑或条状胆固醇神经元.
- 调查VPCN在处理奖励和惩罚信息中的作用.
主要方法:
- 在小鼠中进行向和单交突触逆向标记.
- 在体外急性切片电生理记录VPCNs.
- 大量记录和VPCN的体内电生理学.
主要成果:
- VPCN向底侧杏仁体,中部前额叶皮质和侧面大脑部发射.
- VPCN 接收的输入来自于 核心 accumbens,下丘脑,中枢杏仁体,终端的床核和腹膜区域.
- 大多数VPCN显示爆发发射,类似于基底前脑胆能神经元 (BFCNs),并响应奖励,惩罚和预测线索.
结论:
- 在功能和解剖学上,VPCN与BFCN相似,其特点是爆发式发射.
- VPCN在将厌恶和食欲刺激信息传递到强化电路中发挥着至关重要的作用.
- VPCN的功能障碍可能与情绪障碍和成有关.
相关概念视频
Cholinergic Neurons: Neurotransmission
5.4K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
5.4K
Cholinergic Antagonists: Therapeutic Uses
1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
Cholinergic Receptors: Muscarinic
5.1K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
5.1K
Cholinergic Receptors: Nicotinic
5.6K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.6K
Cholinergic Antagonists: Pharmacokinetics
950
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
950
Cholinergic Antagonists: Pharmacological Actions
1.7K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.7K


